Reference:
RT00497
Inventors have surprisingly found that Emricasan is a much more potent inhibitor of monocyte […]
The inventors have surprisingly demonstrated that GD3 positive senescent cells inhibit NK cell in […]
The present invention relates to the treatment of idiopathic pulmonary fibrosis. Today, there is no […]
Research tool licensing team
researchtools@inserm-transfert.fr
User accounts are momentarily unavailable
The Inserm Transfert website is currently undergoing maintenance. It will be available again in a few hours.